BioreclamationIVT has acquired Asterand Bioscience™, a global provider of human tissue and research solutions with a focus on the oncology market. Asterand Bioscience advances drug research by accelerating target identification and biomarker validation, and improving drug candidate selection to increase the likelihood of clinical success. “We are delighted that Asterand Bioscience’s talented staff is joining…

$17.5 million investment makes Fort Worth the largest sterilization facility in Sterigenics’ global network. Sterigenics International LLC, the leading global provider of contract sterilization, lab services, gamma technologies and medical isotopes, and a portfolio company of Warburg Pincus and GTCR, announces the completion of another major expansion, this time to its Fort Worth, Texas facility, making it…

Amerijet International Airlines – first U.S. all-cargo airline to earn CEIV certification. Amerijet International is the first all-cargo airline of U.S. origin to earn IATA’s CEIV-Pharma certification after being awarded the designation on June 27, 2017. Successful completion of the certification process allows Amerijet to strengthen its promise to exceed the high standards set by the…

Valeant Pharmaceuticals completes sale of Dendreon to Sanpower Group. Valeant Pharmaceuticals International, Inc. announced that its affiliate has completed the sale of all of the outstanding equity interests in its former subsidiary Dendreon Pharmaceuticals LLC to the Sanpower Group, Co., Ltd., for $819.9 million in cash. Valeant will use net proceeds from the sale to permanently repay term…

Imprimis Pharmaceuticals sells pennsylvania facility and sinus assets. Imprimis Pharmaceuticals, Inc., an ophthalmology-focused pharmaceutical company, announced it has entered into an agreement to sell its Folcroft, Pennsylvania facility and sinus related assets for $450,000. The closing of this transaction is expected to occur on or around July 17, 2017, subject to customary terms and conditions.  Mark L. Baum, CEO of…